secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2024-07-05T23:59:59+00:00
Accession:  0001213900-24-059530
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio director Edgardo Baracchini resigns from board effective July 5, 2024
--------------------------------------------------------------------------------

- Baracchini had served on the board since August 2019.
- He was chairman of the Compensation Committee and a member of the Nominating and Corporate Governance Committee.
- Resignation is not due to any disagreement with company policies, operations, or practices.
- No replacement has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390024059530/0001213900-24-059530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390024059530/ea0208951-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-059530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer